Pulmonology

Most pediatric pneumonia cases are caused by respiratory viruses, not bacterial infections, according to findings published in NEMJ.

Previous studies have suggested that patients with multiple sclerosis may not be able to handle a high intensity weight training program. One recent work has shown that may not be the case.

The US Food and Drug Administration approved a new use for sirolimus, treating a rare lung disease.

Patients with chronic obstructive pulmonary disease who use inhaled corticosteroids have a decreased risk of dying from pneumonia, but face an increased risk of contracting the infection.

Researchers at ATS 2015 reported chronic obstructive pulmonary disease was a risk factor for cardiovascular disease, but was not independently linked to risk of stroke or systemic embolism.

Boehringer Ingelheim announced Tuesday the US Food and Drug Administration (FDA) approved once-daily Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray to treat airflow obstruction in patients suffering from chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

The author reviews several important changes to this year's vaccine recommendations for adults and children from the CDC.